In vivo screening of flavonoid compounds revealed quercetin as a potential drug to improve recovery of angiostrongyliasis after albendazole treatment

Ho Yin Pekkle Lam,Yu-Ting Huang,Ting-Ruei Liang,Shih-Yi Peng
DOI: https://doi.org/10.1371/journal.pntd.0012526
2024-10-01
PLoS Neglected Tropical Diseases
Abstract:Human angiostrongyliasis, caused by consuming the larva stage of Angiostrongylus cantonensis , is an infectious disease involving the central nervous system (CNS) and ophthalmic system. Current treatment of angiostrongyliasis involves albendazole accompanied by analgesics and corticosteroids. However, long-term use of corticosteroids may lead to significant adverse effects. In the current study, we screened through different potentially effective flavonoid compounds and identified quercetin as an effective anti-inflammatory agent in an angiostrongyliasis mouse model. Our results identified that quercetin may reverse the neurological defects in mice with angiostrongyliasis. The brain pathology and inflammatory status were also improved by albendazole-quercetin co-therapy. Further analysis showed that albendazole-quercetin co-therapy had a better therapeutic effect than albendazole or quercetin monotherapy. This therapeutic effect was achieved by inhibiting the brain inflammasome activation and apoptosis. Albendazole-quercetin co-therapy also leads to the inhibition of brain IL-5, possibly leading to improved pathology. Our results here proved that quercetin may serve as a potential adjuvant drug in treating human angiostrongyliasis. Human infection following accidental consumption of Angiostrongylus cantonensis can cause eosinophilic meningoencephalitis. Albendazole is the drug of choice for treatment, followed by continuous use of analgesics and corticosteroids, which may have safety concerns. On the other hand, flavonoids are derived from natural plants and have been shown to improve cognitive function by inhibiting the central nervous system (CNS) inflammation. However, the effect of flavonoids combined with albendazole in treating angiostrongyliasis is still unclear. In the current study, we aimed to investigate the therapeutic potential of flavonoids in combination with albendazole for A . cantonensis infection. Our results found that quercetin exhibited the most significant therapeutic effect with albendazole, by which the combined regimen improved the brain histopathology and recovered the mice's neurological functions. This combined therapy also reduces inflammasome activation, pyroptosis, apoptosis, and immune imbalance in the infected mouse brains. Our current study indicated that quercetin possessed the potential as an anti-inflammatory drug and may be helpful in the treatment of A . cantonensis- induced meningoencephalitis.
tropical medicine,parasitology
What problem does this paper attempt to address?